I am interested in how medical comorbidities among ischemic stroke patients may be both novel stroke risk factors and adversely affect outcomes (e.g., mortality and readmission rates). Several areas that I am active examining include the role of HIV and stroke risk in the era of HAART, hematologic abnormalities associated with higher mortality rates among stroke patients, and addressing cardiac screening in this high risk vascular population.
Extensive Research Description
HIV and Ischemic Stroke in the era of combined antiretroviral therapy
HIV and Hemorraghic Stroke in the era of combined antiretroviral therapy
Cardiovascular Screening among Stroke Patients
Statins and Cerebrovascular Disease among those with HIV
Thrombocytopenia and Ischemic Stroke Mortality
Screening for Obstructive Sleep Apnea in Stroke Patients
- Thrombocytopenia and in-hospital mortality risk among ischemic stroke patients. Sico JJ, Phipps MS, Concato J, Wells CK, Lo AC, Nadeau SE, Williams LS, Peixoto AJ, Gorman M, Boice JL, Bravata DM. J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e99-e102. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.005. Epub 2012 Sep 10.